KURLAND FRED 4
4 · Aridis Pharmaceuticals, Inc. · Filed Dec 7, 2022
Insider Transaction Report
Form 4
KURLAND FRED
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2022-12-05+8,000→ 8,000 total→ Common Stock (8,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]4,000 shares of Common Stock will vest on June 5, 2023 and 4,000 will vest on 12/5/2023. In the event that the Reporting Person's employment is terminated without cause by the Issuer, the RSUs will immediately vest.